CIK 0001830214 · Accelerated filer
Ginkgo Bioworks Holdings, Inc.
Sign in to watch- Ticker
- DNA
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 872652913
- Phone
- (877) 442-5362
- Business address
- 27 DRYDOCK AVENUE, 8TH FLOOR, BOSTON, MA, 02210
- Former names
- Soaring Eagle Acquisition Corp., Spinning Eagle Acquisition Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,380,090
- in 7 filings
Net −$1,380,090. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-19 | Kelly Jason R See remarks | Sale | −45,682 | $10.14 | $463K | 129,065 |
| 2026-10-16 | Kelly Jason R See remarks | Option exercise | +55,694 | 148,957 | ||
| 2026-10-16 | Kelly Jason R See remarks | Option exercise | +25,790 | 174,747 | ||
| 2026-10-16 | Kelly Jason R See remarks | Option exercise · Restricted Stock Units | −55,694 | 18,564 | ||
| 2026-10-16 | Kelly Jason R See remarks | Option exercise · Restricted Stock Units | −25,790 | 283,677 | ||
| 2026-07-28 | Kelly Jason R See remarks | Grant or award · Restricted Stock Units | +74,258 | 74,258 | ||
| 2026-07-28 | Kelly Jason R See remarks | Grant or award · Restricted Stock Units | +309,467 | 309,467 | ||
| 2026-04-09 | Kelly Jason R See remarks | Sale | −109,767 | $6.40 | $702K | 316,483 |
| 2026-04-08 | Kelly Jason R See remarks | Option exercise | +212,949 | 523,265 | ||
| 2026-04-08 | Kelly Jason R See remarks | Sale | −97,015 | $6.93 | $672K | 426,250 |
| 2026-04-08 | Kelly Jason R See remarks | Option exercise · Performance-Based Restricted Stock Unit | −212,949 | 0 | ||
| 2026-04-07 | Kelly Jason R See remarks | Option exercise | +212,949 | 310,316 | ||
| 2026-04-07 | Kelly Jason R See remarks | Option exercise · Performance-Based Restricted Stock Unit | −212,949 | 212,949 | ||
| 2024-04-25 | Kelly Jason R See remarks | Grant or award · Stock Option | +5,000,000 | 5,000,000 | ||
| 2024-01-04 | Kelly Jason R See remarks | Sale 10b5-1 | −100,000 | $1.56 | $156K | 3,894,680 |
| 2024-01-03 | Kelly Jason R See remarks | Sale 10b5-1 | −100,000 | $1.54 | $154K | 3,994,680 |
| 2023-12-21 | Kelly Jason R See remarks | Sale 10b5-1 | −100,000 | $1.74 | $174K | 4,094,680 |
| 2023-12-20 | Kelly Jason R See remarks | Sale 10b5-1 | −100,000 | $1.79 | $179K | 4,194,680 |
| 2023-12-14 | Kelly Jason R See remarks | Sale 10b5-1 | −100,980 | $1.63 | $164K | 4,294,680 |
| 2023-12-13 | Kelly Jason R See remarks | Sale 10b5-1 | −99,020 | $1.34 | $133K | 4,395,660 |
Page 1 of 7 · 123 trades